Trial intelligence / Profile preview

AEGR-733 and Atorvastatin in Moderate Hypercholesterolemia

NCT00474240Phase 2Completed

Sponsor
Aegerion Pharmaceuticals
Start
Apr 2007
Primary completion
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lomitapide in hypercholesterolemia, sponsored by Aegerion Pharmaceuticals. Started Apr 2007; status: completed.

02

Drugs

lomitapide
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT00474240.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00474240.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call